Market evolution: Acyclic amides (CN 292419) — 2015–2025

Introduction

This report examines the evolution of EU trade in acyclic amides and their derivatives (Customs code 292419) over the period 2015–2025. This product category covers a broad range of organic chemicals used as intermediates in pharmaceuticals, agrochemicals, and specialty applications. The analysis draws on EU trade data with non-EU countries, production statistics from the Prodcom survey (code 21.10.20.60), and market structure indicators. Three key dynamics emerge: a structural reorientation of trade flows toward Asian suppliers, a dramatic increase in unit values that masks declining physical volumes, and a significant shift in the EU's strategic position from net exporter to near-balance.

1. A market transformed by volume-price divergence and shifting trade balances

1.1 Export values rose while volumes collapsed, signalling a fundamental product mix shift

Over the 2015–2025 period, EU exports of acyclic amides evolved in opposite directions depending on the metric considered. In value terms, exports grew from €259.6 million to €365.5 million, an increase of +40.8% (General Overview). However, export quantities fell sharply from 145,699 tonnes to 90,195 tonnes, a contraction of −38.1%. This divergence is explained by a dramatic increase in export unit prices, which rose from €1,781 per tonne to €4,051 per tonne (+127.4%), peaking at €4,792 per tonne at their highest point.

This pattern strongly suggests that the EU has moved up the value chain, exporting higher-value, more specialised acyclic amides rather than competing on volume with lower-cost producers. Indeed, EU production data confirms this interpretation: while production volumes fell by 15.3% (from 708,264 kg to 600,000 kg), production values surged by 173.9% (from €474.6 million to €1.3 billion).

1.2 Import growth was driven by rising volumes, not rising prices

In contrast to the export pattern, EU imports grew primarily through volume expansion rather than price increases. Import quantities rose from 59,891 tonnes to 105,097 tonnes (+75.5%), while import values climbed from €230.0 million to €373.5 million (+62.4%). Notably, import unit prices actually declined slightly from €3,839 per tonne to €3,551 per tonne (−7.5%), suggesting increased competition among foreign suppliers and favourable pricing for EU buyers.

1.3 The EU swung from a comfortable trade surplus to a marginal deficit

The combined effect of these diverging trends was a reversal of the EU's trade position. In 2015, the EU enjoyed a trade surplus of €29.6 million in acyclic amides. By 2025, this had turned into a deficit of −€8.0 million, a deterioration of −126.9% (General Overview). The deficit was even more pronounced at its worst point, reaching −€126.0 million, before partially recovering. This swing reflects the EU's growing appetite for imported volume in standard-grade acyclic amides, even as its export performance in higher-value segments improved.

2. China's import dominance reshaped the EU's supply geography

2.1 China emerged as the overwhelmingly dominant import supplier

The most striking geographic shift in EU acyclic amide trade was the meteoric rise of China as an import source. Chinese imports into the EU grew from €38.9 million in 2015 to €167.3 million in 2025, an extraordinary increase of +329.7% (top partners). At its peak, Chinese imports reached €225.8 million. By 2025, China alone accounted for nearly 45% of total EU imports of this product, up from roughly 17% in 2015.

This dominance is further reflected in the Herfindahl-Hirschman Index (HHI) for imports, which rose from 1,386 to 2,462 (+77.6%) by value and from 1,469 to 2,741 (+86.6%) by volume. An HHI above 2,500 is generally considered to indicate a highly concentrated market, meaning the EU's import supply of acyclic amides has become substantially less diversified over the decade.

2.2 India also gained ground, while traditional European partners lost share

India, the second-largest import source, saw its exports to the EU grow from €30.4 million to €56.2 million (+84.6%). Together, China and India now represent approximately 60% of EU acyclic amide imports, up from about 30% in 2015. Meanwhile, traditional suppliers closer to the EU saw stagnation or decline: the United Kingdom (−20.5%), Switzerland (−22.5%), and Saudi Arabia (−45.0%) all lost ground. The UK decline is partly attributable to post-Brexit trade frictions, though volumes were already trending down before 2021.

2.3 Export destinations shifted toward the Americas and Switzerland

On the export side, the geographic pattern also changed substantially. Exports to the United States grew from €57.6 million to €106.3 million (+84.4%), making the US the EU's single largest export market by 2025. Exports to Brazil surged from €7.9 million to €24.9 million (+214.7%), and to Switzerland from €31.1 million to €64.9 million (+108.4%). In contrast, exports to the United Kingdom fell dramatically from €69.4 million to €37.8 million (−45.5%), displacing the UK from its position as the EU's top export destination in 2015.

2.4 Export concentration remained stable despite shifting partners

Unlike the rising import concentration, the export HHI remained relatively stable, declining marginally from 1,475 to 1,451 (−1.6%) by value. This indicates that while the composition of export partners changed significantly, the overall level of diversification was maintained—a positive sign for EU exporters' market resilience.

3. Supply-side shocks and increasing import concentration raise strategic concerns

3.1 The EU's net import reliance improved on paper but masks vulnerability

The net import reliance indicator suggests the EU's position improved dramatically, falling from +31.5% in 2015 to just +2.5% in 2025 (a −92.1% change). However, this figure fluctuated significantly throughout the period, reaching as low as −90.6% in some years (indicating the EU was a net exporter of over 90% of apparent consumption). The volatility of this indicator—rather than its absolute level—is itself a concern, as it reflects unstable trade dynamics.

3.2 Trade intensity and export propensity both declined, signalling domestic market orientation

Trade intensity fell from 64.5% to 40.6% (−37.1%), while export propensity declined from 35.6% to 24.5% (−31.1%). These declining ratios suggest that the EU's acyclic amide sector has become more oriented toward serving domestic demand and less reliant on export markets—a pattern consistent with growing import substitution and a reorientation of production toward serving European end-users.

3.3 Price shocks in UK and US trade highlighted supply chain vulnerabilities

The volatility analysis detected several notable supply shocks. The most extreme was a price shock in imports from the United Kingdom centred on 2021, with an abnormality score of 1,152.6 and a price shift of +129.0%. This coincides with post-Brexit supply chain disruptions and the broader global logistics crisis. On the export side, price shocks were detected for the United States (2022, +36.0%) and Türkiye (2022, +46.1%), likely linked to the energy price surge and supply chain pressures following the Russia-Ukraine conflict.

The United Kingdom also exhibited the highest export-side volatility among all EU partners, with a coefficient of variation (CV) of 1.16—indicating extremely unstable export flows. On the import side, China (CV 0.63) and South Korea (CV 0.66) showed the highest volatility, though this may reflect lumpy contract-based shipments rather than structural instability.

3.4 Intra-EU specialisation reveals a concentrated production base

Within the EU, specialisation in acyclic amide production is heavily concentrated in a few member states. Belgium (RSCA 0.38, RCA 2.23) and Spain (RSCA 0.37, RCA 2.18) are the most specialised producers, followed by Germany (RSCA 0.23, RCA 1.59). Germany alone accounts for 33.7% of EU production and 21.2% of total trade value, underscoring its central role. France (RCA 1.32) and Greece (RCA 1.14) show moderate specialisation. At the other extreme, Luxembourg, Cyprus, Romania, Lithuania, and Portugal have negligible production and negative RSCA scores, confirming they are purely consumers or re-exporters.

Conclusion

The EU market for acyclic amides (CN 292419) underwent a profound structural transformation between 2015 and 2025. The most significant development was the emergence of China as the dominant import supplier, with import values from China increasing by over 330%. This shift, combined with growing imports from India, fundamentally altered the EU's supply geography and drove a sharp increase in import concentration, raising potential concerns about supply chain resilience.

Paradoxically, the EU simultaneously improved its value-added position: export unit prices more than doubled while production values nearly tripled, even as physical volumes declined. This points to a strategic move toward higher-value, specialised acyclic amides—a pattern consistent with the EU's broader chemical industry strategy of competing on quality and innovation rather than cost.

Looking forward, the key risks centre on the growing dependence on Asian suppliers, the volatility of trade flows with the United Kingdom following Brexit, and the concentration of intra-EU production in just a handful of member states. The data suggests that while the EU has successfully moved up the value chain, it has done so at the cost of greater import dependency for standard-grade products—an industrial policy trade-off that will warrant continued monitoring.